Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection - Concepedia

Concepedia

Publication | Open Access

Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection

DOI Full Paper Access

71

Citations

8

References

2017

Year

Vicente Boix, Richard N. Fedorak, Kathleen M. Mullane, Yves Pesant, Uschi Stoutenburgh, Mandy Jin, Adedayo Adedoyin, Laurent Chesnel, Dalya Güriş, Kajal Larson,

Open Forum Infectious Diseases

Abstract

Surotomycin failed to meet the criteria for noninferiority versus vancomycin for the primary and key secondary endpoints in this trial.

References

	Year	Citations

Page 1